Singapore markets close in 3 hours 44 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
340.88-4.86 (-1.41%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
7,019,395
803,395
60,209
135,068
205,825
Cost of revenue
950,933
7,933
-
-
-
Gross profit
6,068,462
795,462
-
-
-
Operating expenses
Research development
1,925,339
1,370,339
496,309
454,082
410,459
Selling general and administrative
325,267
188,267
109,620
94,252
64,722
Total operating expenses
2,250,606
1,558,606
605,929
548,334
475,181
Operating income or loss
3,817,856
-763,144
-545,720
-413,266
-269,356
Interest expense
13,886
9,886
6,612
-
-
Total other income/expenses net
-1,198
3,802
-914
1,835
-1,875
Income before tax
3,819,487
-744,513
-514,716
-384,408
-255,996
Income tax expense
324,551
2,551
-695
326
-80
Income from continuing operations
3,494,936
-747,064
-514,021
-384,734
-255,916
Net income
3,494,936
-747,064
-514,021
-384,734
-255,916
Net income available to common shareholders
3,494,936
-747,064
-514,021
-401,857
-269,841
Basic EPS
-
-1.96
-1.55
-1.17
-0.97
Diluted EPS
-
-1.96
-1.55
-1.17
-0.97
Basic average shares
-
381,333
330,802
328,799
269,649
Diluted average shares
-
381,333
330,802
328,799
269,649
EBITDA
-
-703,376
-477,083
-388,404
-248,819